duloxetine hydrochloride has been researched along with Adverse Drug Event in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Makino, J; Mitsuboshi, S; Neo, M; Nishihara, M; Suzuki, K; Yamada, T | 1 |
| Koyama, K | 1 |
| Demirel, K; Ocak, H; Tüten, B; Yalçınkaya, B; Yazar, B | 1 |
| Bomfati, F; de Oliveira Filho, GR; Erdmann, TR; Gaspareto, PB; Gerber, MT; Lyra, HF | 1 |
| Cao, Y; Chen, C; Chen, X; Zhou, Y | 1 |
| Hadryś, T; Machowska, M; Maciaszek, J; Misiak, B; Pawłowski, T; Wiela-Hojeńska, A | 1 |
| Adams, EJ; Hu, S; Huang, KM; Loprinzi, CL; Lustberg, MB | 1 |
| Cheng, Y; Dowsett, SA; Elpers, J; Hoog, SL | 1 |
| Acuna, C | 1 |
| Chappell, AS; D'Souza, DN; Kajdasz, DK; Littlejohn, G; Moldofsky, H; Scheinberg, M | 1 |
| Desaiah, D; Detke, MJ; Kennedy, SH; Pangallo, BA; Perahia, DG; Zhang, Q | 1 |
| Methfessel, HD; Michel, MC; Minarzyk, A; Quail, D; Schwerdtner, I; Weber, HJ | 1 |
| Baygani, SK; Hurley, DJ; Turner, CL; Viktrup, L; Yalcin, I | 1 |
| Carter, WP; Mallinckrodt, CH; Prakash, A; Watkin, JG; Wohlreich, MM | 1 |
3 review(s) available for duloxetine hydrochloride and Adverse Drug Event
| Article | Year |
|---|---|
The efficacy and safety of duloxetine for the treatment of patients after TKA or THA: A systematic review and meta-analysis.
Topics: Analgesics, Opioid; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Humans; Knee Joint; Pain Management; Randomized Controlled Trials as Topic | 2023 |
Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy.
Topics: Antineoplastic Agents; Clinical Trials, Phase III as Topic; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Humans; Peripheral Nervous System Diseases; Quality of Life; Randomized Controlled Trials as Topic | 2019 |
Duloxetine for the treatment of fibromyalgia.
Topics: Antidepressive Agents; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Fibromyalgia; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Thiophenes | 2008 |
4 trial(s) available for duloxetine hydrochloride and Adverse Drug Event
| Article | Year |
|---|---|
Efficacy of postoperative analgesia with duloxetine in posthemorrhoidectomy pain: a prospective, randomized, double-blind and placebo-controlled trial.
Topics: Analgesia; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Humans; Morphine; Pain; Prospective Studies | 2022 |
A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Comorbidity; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Internationality; Male; Middle Aged; Pain; Pain Measurement; Thiophenes; Treatment Outcome; Young Adult | 2009 |
Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety.
Topics: Adult; Aged; Aged, 80 and over; Constipation; Diarrhea; Disorders of Excessive Somnolence; Dizziness; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Fatigue; Female; Headache; Humans; Liver; Middle Aged; Nausea; Sleep Initiation and Maintenance Disorders; Thiophenes; Urinary Incontinence, Stress; Xerostomia | 2006 |
Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Female; Humans; Long-Term Care; Male; Middle Aged; Personality Inventory; Thiophenes; Treatment Outcome | 2007 |
8 other study(ies) available for duloxetine hydrochloride and Adverse Drug Event
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Risk of Pregabalin-Induced Hypoglycemia: Analysis of the Japanese Adverse Drug Event Report Database.
Topics: Aged; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Gabapentin; Humans; Hypoglycemia; Japan; Neuralgia; Pregabalin | 2022 |
Comparison of efficacy and safety in the combination therapies of duloxetine and S-flurbiprofen plaster, and of duloxetine and conventional NSAIDs for chronic pain in patients with osteoarthritis (OASIS DUAL study).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Pain; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Female; Flurbiprofen; Humans; Male; Osteoarthritis; Treatment Outcome | 2022 |
Duloxetine induced tachycardia: A rare side effect.
Topics: Analgesics; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Fibromyalgia; Humans | 2023 |
The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression.
Topics: Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Depression; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Humans; Polymorphism, Genetic | 2023 |
Duloxetine and pregnancy outcomes: safety surveillance findings.
Topics: Abortion, Spontaneous; Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Female; Humans; Infant; Infant, Newborn; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thiophenes; United States; United States Food and Drug Administration | 2013 |
Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials.
Topics: Adult; Antidepressive Agents; Compassionate Use Trials; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Female; Humans; Male; Medication Adherence; Middle Aged; Outcome Assessment, Health Care; Thiophenes; Time | 2010 |
Observational study on safety and tolerability of duloxetine in the treatment of female stress urinary incontinence in German routine practice.
Topics: Antidepressive Agents; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Female; Germany; Humans; Incidence; Middle Aged; Private Practice; Risk Factors; Thiophenes; Urinary Incontinence, Stress | 2013 |